SABMiller’s Mackay Steps Back After ‘Sudden Worsening’ of Health

SABMiller Plc, (SAB) the world’s second-biggest brewer, said Chairman Graham Mackay is taking a further leave of absence after a “recent sudden worsening” of his health following brain surgery earlier this year.

Deputy Chairman John Manser has been re-appointed as acting chairman, a role he held for five months during Mackay’s initial recovery, the London-based company said today in a statement.

Mackay only returned as chairman two months ago, having been off work following treatment for a brain tumor.

In April, he stepped down early as the brewer’s chief executive officer, a role in which he masterminded a slew of acquisitions, including the A$10.5 billion ($9.8 billion) takeover of Foster’s Group Ltd. in 2011. Alan Clark, a company veteran of more than two decades, replaced Mackay as CEO.

To contact the reporter on this story: Paul Jarvis in London at pjarvis@bloomberg.net

To contact the editor responsible for this story: Celeste Perri at cperri@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.